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Systematic reviewGeneralized AnxietyDisorder (GAD) is typically considered a chronic condition characterizedby excessiveworry.
Lifetime prevalence is 4.3–5.9%, yet only a small percentage seeks treatment. GAD is treatable and in recent years
internet-delivered treatment interventions have shown promise. This paper aims to systematically search for lit-
erature on internet-delivered psychological interventions for the treatment of GAD and conduct a meta-analysis
to examine their efﬁcacy. The purpose of the paper is to inform the community of researchers, program devel-
opers and practitioners in internet delivered interventions of the current state-of-the-art and research gaps
that require attention. A systematic search of the literaturewas conducted to ﬁnd all studies of internet-delivered
treatments for GAD (N=20). Using ReviewManager 5 all Randomized Controlled Trials (RCTs; n=11) thatmet
our established eligibility criteria were included into ameta-analysis that calculated effect sizes via the standard-
ized mean difference. Compared to the waiting-list controls, the results demonstrate positive outcomes for GAD
symptoms (d=−0.91) and its central construct of pathological worry (d=−0.74). Themeta-analysis supports
the efﬁcacy of internet-delivered treatments for GAD including the use of disorder-speciﬁc (4 studies) and
transdiagnostic treatment protocols (7 studies). Caution is advised regarding the results as the data is limited
and highly heterogeneous, but revealing of what future research might be needed.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Generalized Anxiety Disorder (GAD) is characterized by excessive
anxiety andworry, which the sufferer describes as difﬁcult to control, oc-
curring more days than not for a period of at least six months (American
Psychiatric Association [APA], 2013). Other symptoms of GAD include
restlessness, being easily fatigued, difﬁculty concentrating, irritability,
muscle tension, and sleep disturbance. GAD is one of the most prevalent
anxiety disorders (Kessler et al., 2005a; Kessler et al., 2005b; Narrow
et al., 2002). Its one-year prevalence in community samples in the US is
around 3% and its lifetime prevalence around 5% (Blazer et al., 1991;
Kessler et al., 2005a; Kessler et al., 2005b; Wittchen, 2002). Studies from
other countries revealed roughly similar ﬁgures (Bijl et al., 1998;
Faravelli et al., 1989; Hunt et al., 2002; Jenkins et al., 1997). GAD patients
typically present in primary care settings, where the reported prevalence
is up to 8% (Kroenke et al., 2007; Roy-Byrne &Wagner, 2004).
Evidence from retrospective accounts suggest that people with GAD
will have their ﬁrst episode by age 31, with a quarter having their ﬁrst
episode by age 20, with an early onset in childhood or adolescencey College, Dublin, Ireland.
. This is an open access article under(Kessler et al., 2005a). Research suggests that GAD is a chronic and en-
during condition (Angst & Vollrath, 1991; Grant et al., 2005). Further-
more, comorbidity is as high as 90%, with 70% being diagnosed with
comorbid depression, over 55% with any other anxiety disorder and
48%with a somatoform disorder (Carter et al., 2001). Around 50% of pa-
tients with GAD have also a personality disorder, most commonly
avoidant and dependent personality disorder (Sanderson et al., 1994).
Depression is commonly shown to follow GAD (Kessler et al., 2004),
suggesting that chronic GAD may start the onset of depression in
some cases (Barlow, 2002).
People with GAD experience signiﬁcant impairment in quality of life
(Loebach Wetherell et al., 2004; Massion et al., 1993). GAD negatively
impacts the individual's general sense of well-being and life satisfaction
and speciﬁcally occupational and family satisfaction (Stein & Heimberg,
2004). GAD represents a signiﬁcant cost to society due to disability, de-
creased work productivity and increased use of health care services
(Wittchen, 2002).
2. GAD and its treatment
As is the case with other anxiety disorders, cognitive-behavioral
therapy (CBT), a form of psychological therapy, is the treatment that isthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Excellence, 2011). CBT for GAD is well studied and is shown to be more
effective than wait-list, non-speciﬁc control conditions or treatment as
usual (Borkovec & Ruscio, 2001; Hunot et al., 2007; National Institute
for Health and Clinical Excellence, 2011). Several cognitive-behavioral
models of generalized anxiety disorder exist (Brown et al., 2001;
Dugas & Robichaud, 2007). In general, thesemodels assume that people
withGADhad early experiences of uncontrollability (Brown et al., 2001)
or have intolerance of uncertainty on the basis of negative belief (Dugas
& Robichaud, 2007). The worry in GAD aims at avoiding future aversive
events (Borkovec, 1994; Brown et al., 2001)which brings temporary re-
lief, but also inhibition of emotional processing and maintenance of
anxiety-producing thinking and behaviors (Brown et al., 2001). More
cognitive and meta-cognitive models of GAD also stress positive beliefs
about worry's protective function (Wells, 1999).
CBT for GAD includes a number of speciﬁc components such as cogni-
tive restructuring, behavioral exposure to feared consequences,worry ex-
posure (staying with feared outcomes), relaxation training, worry
behavior prevention and problem solving (Borkovec & Ruscio, 2001;
Brown et al., 2001; Covin et al., 2008; Dugas & Robichaud, 2007). Their
main rationale is that the patient overcomes emotional avoidance and
learns that anxiety is not debilitating, but manageable and recedes after
time. Recently, transdiagnostic CBT protocols for depressive and anxiety
disorders have been proposed that also focus on features relevant to
GAD such as emotional avoidance (Barlow et al., 2011). Proponents of
transdiagnostic interventions argue that the similarities between the anx-
iety disorders outweigh their individual differences and they can respond
to common therapeutic procedures (Allen et al., 2007).
3. Access to treatment: the evolution of high and low-intensity
interventions
Healthcare providers are increasingly faced with a discrepancy be-
tween the burden of mental health conditions and the availability of
cost-effective psychological treatments (Kohn et al., 2004). It has been
estimated that upwards of 70% of people with anxiety disorders go un-
treated every year (Andrews et al., 2001; Lepine, 2002). There are mul-
tiple barriers to accessing treatment, including waiting-lists, costs,
distance from service locations, negative perception of treatments, and
personal stigma (Kohn et al., 2004; Mohr et al., 2010).
In recent years a model of stepped-care has evolved, involving
high-intensity (e.g., one-to-one therapy) and low-intensity
(e.g., bibliotherapy, internet-delivered treatments) interventions
(Bower & Gilbody, 2005). Low-intensity internet-delivered inter-
ventions have the potential to extend access and reduce costs and
possibly can overcome some of the barriers mentioned above.
Several studies have reported positive outcomes for internet-
delivered treatments for social phobia, spider phobia, ﬂight and other
phobias, panic disorder, obsessive-compulsive disorder (OCD), post-
traumatic stress disorder (PTSD), stress-related anxiety, trauma, de-
pression and generalized anxiety disorder (GAD) (Cuijpers et al.,
2009; Reger & Gahm, 2009; Richards & Richardson, 2012).
Internet-delivered cognitive behavior therapy treatment protocols
have included disorder-speciﬁc treatments and transdiagnostic treat-
ments that aim to treat the common elements and symptoms for anxi-
ety disorders in general (Andersson et al., 2012; Bell et al., 2012;
Carlbring et al., 2011; Johnston, Titov, Andrews, Spence, & Dear, 2011;
Newby et al., 2013; Paxling et al., 2011; Robinson et al., 2010; Titov
et al., 2010; Titov et al., 2009; Titov et al., 2011). Few internet-delivered
treatments have integrated other therapeutic practices such as brief
psychodynamic therapy (Andersson et al., 2012).
4. Other reviews and meta-analyses
A number of reviews and meta-analyses of this area have been pub-
lished. An early narrative review (Przeworski & Newman, 2006) oftechnology-assisted CBT for anxiety concluded that the ﬁeld was in its
infancy but that existing research was promising and suggested that
technology-based delivery may be efﬁcacious and cost-effective. Reger
and Gahm's (2009) meta-analysis concluded that the data supported
the use of such delivery systems and that the results are superior to
waiting-list or placebo. The study did not review any internet interven-
tions for the treatment of GAD (Reger & Gahm, 2009); there simply
were none published at the time. A similar meta-analysis by Cuijpers
et al. (2009) found a large effect size (d=1.08) for the active conditions
compared to the controls. The authors concluded in favor of the poten-
tial of computer-aided delivery of treatments for anxiety disorders
(Cuijpers et al., 2009). The meta did not include studies for generalized
anxiety disorder. Andrews et al. (2010) published ameta-analysis dem-
onstrating that computerized CBT was superior to outcomes from con-
trol groups. In an analysis of 22 studies of comparisons with a control
group they reported a post-treatment effect size of d = 1.12 for the
studies that examined GAD (Andrews et al., 2010).
To date, the data available for the relevance of internet-delivered
treatments on outcomes speciﬁcally in GAD-diagnosed subjects is
scarce. In recent years, principally using internet-delivery, other studies
have been published. A recent meta-analysis by Cuijpers et al. (2014)
examined the effectiveness of psychological therapy for GAD. While it
included studies using internet interventions it was not their primary
focus.
In 2013, Cochrane published a review of media-delivered cognitive
behavior therapy and behavior therapy (self-help) for anxiety disorders
in adults (Mayo-Wilson & Montgomery, 2013). Some of the studies in
that review we include here also. The other studies they included for
GAD are unpublished data from Kiely (2002), Houghton (2008), and
Shoenberger (2008). They included Bowman (1997), but the media
used was worksheets on paper (not computer or internet-delivered)
and lastly Rosmarin (2010), which included a sub-clinical anxiety
group, not GAD symptom-speciﬁc group. Their search period ended Jan-
uary 1 2013 and further (n=4) studies have been published since that
time. Similarly, Christensen et al. (2014) included a search period of 18
months from 2012 to June 2013 and included two studies for GAD, but
since that time other studies have been published.
The current study therefore aimed to bemore speciﬁc and systemat-
ically review and conduct ameta-analysis of internet-delivered psycho-
logical therapy for GAD compared to waiting-list control groups. The
purpose of the paper is to inform the community of researchers, pro-
gram developers and practitioners in internet-delivered interventions
of the current state of the art and research gaps that require attention.
The paper presents a comprehensive search of the literature, an effort
to gather discrete data on subjects, and a detailed focus on the efﬁcacy
of internet interventions on GAD speciﬁc and some co-morbid (depres-
sion, distress, disability and quality of life) symptoms.5. Method
5.1. Literature search and selection of studies
The aim of our literature searchwas to ﬁnd all studies that related to
internet-delivered treatment protocols for GAD, including disorder-
speciﬁc protocols and more recent transdiagnostic protocols. During
June 2013, we selected three prominent databases (Embase, PubMed,
and PsychINFO including PsychARTICLES) as our search arena. After ini-
tial experimentation with several search phrases (online delivered
treatments for anxiety/generalis[z]ed anxiety, web-based treatment/in-
terventions for anxiety, among others) that were derived from the au-
thors' experiences in internet-delivered treatments and also from
known studies, we decided on the use of three key search phrases that
wewere conﬁdentwould yield the relevant literature. Theywere ‘inter-
net treatment for generalized anxiety disorder’ and ‘internet treatment
for generalized anxiety disorder’ and ‘internet treatment for anxiety’.
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culminating in a total of nine searches.
Initially, search results were excluded at title depending on their rel-
evance, thereafter abstracts were read and further papers excluded.
Lastly the remaining papers were read fully and excluded if they were
not eligible (for eligibility criteria see below). Finally, the reference
lists of accepted papers and other reviews and meta-analysis
(Andrews et al., 2010; Cuijpers et al., 2009; Przeworski & Newman,
2006; Reger & Gahm, 2009) were checked for further relevant papers.
The process was conducted by the ﬁrst two authors (DR, TR) and any
disagreements that arose were discussed until a ﬁnal decision was
reached.
Eligibility criteria was established to include studies that were ran-
domized controlled trials of an internet-delivered intervention com-
pared to a waiting-list control. The studies were based on adult (18+
years) samples that had a clinical diagnosis of GAD, whom may have
had comorbidity with depression and/or impairment in functioning.Fig. 1. Results from theSo as to include discrete outcomes for patients undergoing treatment
for GAD, studies that employed transdiagnostic anxiety treatment pro-
tocols had to discriminate outcomes for the different anxiety disorders
to be included. In some cases where a transdiagnostic protocol was
employed and/or outcomes from several anxiety disorders reported in
total for participants, we contacted authors to get the discrete outcomes
data for the GAD diagnosed subjects. All the studies were published in
peer-reviewed journals in English and included reliable and valid mea-
sures for the assessment of outcomes, such as Generalized Anxiety
Disorder-Q-IV (Newman et al., 2002) and Generalized Anxiety
Disorder-7 (Spitzer et al., 2006) and the Penn State Worry Question-
naire (Meyer et al., 1990).
Post data-analysis andmanuscript preparation, we carried out a fur-
ther search and due to time lapsed, included the original search arena
and added the Cochrane database, and then also did a search by cite.
The search yielded one further study, but it did not meet our eligibility
criteria for inclusion in the meta-analysis (Boettcher et al., 2014).systematic search.
Table 1
Studies included in the systematic review.
Study Participants Sample Design Intervention Support Measures Country
*Andersson et al.
(2012)
Telephone administered SCID-I
diagnosis for GAD
Community (n= 81) RCT:
ICBT: 27
IPDT: 27
WL: 27
ICBT
IPDT — SUBGAP
8 content modules/8 weeks
Therapistv (ﬁnal year clinical psychology
trainees and one licensed psychologist)
PSWQ
GAD-IV
MADRS-S
BAI
BDI-II
QOLI
STAI
Sweden
*Bell et al. (2012) Referrals to anxiety disorder unit.
SCID-I administered in person.
Clinical (n= 83) RCT:
CCBT: 7
WL: 7
CCBT: 4 sessions of CBT within
12 weeks
WL
Research assistant (not clinical) telephone
call every 2 weeks for compliance.
WASA
GADI
PSWQ
BDI-II
New Zealand
*Berger et al. (2013) Telephone administered SCID-I
diagnosis for GAD
Community (n= 132: sample
recruited from Germany,
Switzerland and Austria)
RCT
TAiCBT: 44
STiCBT: 44
WL: 44
ICBT — 8-content modules/8
weeks
Masters level therapists (ﬁnal year clinical
psychologists, a qualiﬁed psychologist, and a
qualiﬁed CBT therapist) weekly written
feedback.
BAI
BDI-II
GSI (BSI)
SPS
SIAS
ACQ
BSQ
MIA
MIB
PSWQ
Switzerland
Boettcher et al.
(2014)
Telephone administered SCID-I
diagnosis for anxiety disorder
Community (n= 91) RCT
IBMT: 45
WL: 46
Internet-based mindfulness
treatment for anxiety
disorders (transdiagnostic) 8
modules/8 weeks
None for intervention group. Supervised
discussion forum for WL group.
BAI
BDI-II
ISI
QOLI
Sweden
(recruitment through website
and newspaper adverts)
Carlbring et al.
(2011)
In person administered SCID for
diagnosis of an anxiety disorder
Community
(n= 54)
RCT
iCBT: 27
Control: 27
Individually tailored CBT for
comorbid anxiety disorders
(and depression).
6–10 modules (out of 16)/10
weeks.
Advanced MSc Clinical Psychology students.
Weekly e-mail feedback.
BAI
CORE-OM
MADRS-S
QOLI
Sweden
(recruitment through website, ra-
dio interviews, and newspaper
adverts)
Craske et al. (2011) MINI for diagnosis of 1 or more anxiety
disorders.
Clinical (n= 1004) RCT
iCBT: 503
(270 GAD)
Control: 501
(279 GAD)
iCBT disorder-speciﬁc (PD,
PTSD, GAD, SAD)
8 modules/10–12 weeks
Practitioners (social workers, nurses, MSc
and PhD-level psychologists) worked
collaboratively with Ps in person as they
completed the program.
PDSS-SR
GADSS
SPIN
PCL-C
USA
(recruitment through referral in
primary care setting)
Dear et al. (2011) MINI telephone-administered Community (n= 32) Open trial
(single-sample)
iCBT transdiagnostic
depression and anxiety
disorders
5 modules/8 weeks
Clinical Psychologist
Weekly telephone or text-based support
DASS-21
PHQ-9
PSWQ
SIAS6/SPS6
PDSS-SR
GAD-7
K-10
SDS
NEO-FFI-N
Australia
Draper et al. (2008) In person administered SCID for
diagnosis of GAD
Clinical (n= 3) Multiple case series iCBT (GAD-speciﬁc)
11 modules/11 weeks
Encouragement provided by “occasional”
telephone contact (do not specify who
provided contact)
PSWQ
GADQ-IV
MCQ-30
Australia
*Johansson et al.
(2013)
Telephone administered MINI
interview diagnosis for depression and
anxiety disorder
Community (n= 100) RCT:
IPDT: 50
WL: 50
Based on APT model
8 content modules/10 weeks
Masters level therapists. Weekly written
feedback.
PHQ-9
GAD-7
EPS-25
FFMQ
Sweden
*Johnston et al.
(2011)
Telephone administered MINI diagnosis
for GAD, social phobia, or panic
disorder
Community (n= 139) RCT:
ICBT-CL: 46
ICBT-CO: 47
WL: 46
Anxiety Program of 8 content
modules/10 weeks
Weekly telephone or email contact from
either clinician or coach
GAD-7
DASS-21
PSWQ
SIAS-6
SPS-6
PDSS-SR
PHQ-9
SDS
Australia
(continued on next page)
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Table 1 (continued)
Study Participants Sample Design Intervention Support Measures Country
Klein et al. (2011) “e-PASS” online Ax (540 items
corresponding to DSM-IV-TR criteria)
to refer clients to program appropriate
to their difﬁculties.
Community (n= 225) Quasi-experimental
(naturalistic
participant choice).
GAD = 88
5 iCBT programs speciﬁc to
GAD, PD/A, OCD, PTSD, or
SAD.
12 modules/12 weeks
e-mail support.
Therapists or postgraduate psychology
students.
K-6
e-PASS
Australia
Mewton et al. (2012) Referred by practitioners. Clinical (n= 588) Naturalistic
single-sample
iCBT GAD speciﬁc 6
modules/time not speciﬁed
Nature of support not speciﬁed. Prescribing
practitioner received updates on client
progress
GAD-7
K-10
WHODAS
Australia
*Newby et al. (2013) telephone administered MINI to
conﬁrm diagnosis of GAD and/or MDD
Community (n= 109) RCT:
ICBT: 49
WL: 60
Worry and sadness program –
6 content modules/10 weeks
Regular therapist contact for ﬁrst two
modules, as needed subsequently.
(telephone/e-mail)
PHQ-9
GAD-7
K-10
WHODAS-II
BDI-II
PSWQ
NEO-FFI-N
Australia
*Paxling et al. (2011) Telephone administered SCID-I
diagnosis for GAD
Community (n= 89) RCT:
ICBT: 44
WL: 45
ICBT – 8 content modules/8
weeks
Therapist — weekly email feedback PSWQ
GAD-IV
STAI
BAI
BDI
MDRS
QOLI
Sweden
*Robinson et al.
(2010)
Telephone administered MINI diagnosis
for GAD
Community (n= 150) RCT:
ICBT-TA:50
ICBT-CA: 51
WL: 49
ICBT 6 content modules/10
weeks
Weekly supportive e-mail or telephone
contact from Therapist (clinical psychologist)
or technician (clinic administrator).
PSWQ
GAD-7
K-10
SDS
PHQ-9
Australia
Sunderland et al.
(2012)
Primary diagnosis of GAD or
depression, referred by GP/mental
health professional.
Clinical (n = 663) Naturalistic
single-sample
iCBT dep: 302
iCBTanx: 361
iCBT for GAD
(and iCBT for depression)
6 modules/10 weeks
Progress overseen by prescribing clinician (level
and method of contact not speciﬁed)
K-10
PHQ-9
GAD-7
Australia
*Titov et al. (2009) Telephone administered MINI diagnosis
for GAD
Community (n= 48) RCT:
ICBT: 25
WL: 23
ICBT 6 content modules/9
weeks
Weekly therapist support (clinical
psychologist)
GAD-7
PSWQ
PHQ-9
K-10
SDS
Australia
*Titov et al. (2010) Telephone administered MINI diagnosis
for GAD, social phobia, panic disorder
Community (n= 86) RCT:
ICBT: 42
WL: 44
ICBT Anxiety 6 content
modules/8 weeks
Weekly text-based and/or telephone contact
from therapist (clinical psychologist)
GAD-7
PSWQ
SPSQ
PDSS-SR
PHQ-9
K-10
SDS
DASS-21
Australia
*Titov et al. (2011) Telephone administered MINI diagnosis
for anxiety disorder or depression
Community (n= 78) RCT:
ICBT: 39
WL: 38
Wellbeing program — 8
content modules/10 weeks
Weekly text-based and/l or telephone from
therapist (clinical psychologist)
DASS-21
PHQ-9
PSWQ
SP-12
PDSS-SR
GAD-7
K-10
SDS
Australia
Zou et al. (2012) Telephone administered MINI for
diagnosis of an anxiety disorder
Older adult community
(n= 22)
Single sample iCBT for anxiety disorders
(transdiagnostic)
5 modules/8 weeks
Clinical psychologist. Weekly telephone or
e-mail support.
GAD-7
DASS-21
PHQ-9
SDS
K-10
Australia
Note. * = indicates studies included in the meta-analysis; SCID-I = Structured Clinical Interview for DSM-IV Axis I Disorders; DSM-IV=Diagnostic and Statistical Manual for Mental Health Disorders-IV; MINI = International Neuropsychiatric Interview;
GAD=Generalized Anxiety Disorder; MDD=Major Depressive Disorder; RCT= Randomized Controlled Trial; ICBT= Internet Cognitive Behavior Therapy; IPDT= Internet Psychodynamic Therapy; WL=Waiting-List; APT= Affect-Phobia Therapy;
TAiCBT= Tailored internet cognitive behavior therapy; STiCBT = Standardized internet cognitive behavior therapy; PSWQ= Penn State Worry Questionnaire; GAD-IV = Generalized Anxiety Disorder-IV; MADRS-S =Montgomery–Åsberg Depression
Rating Scale; BAI=BeckAnxiety Inventory; BDI-II=BeckDepression Inventory-II; QOLI=Quality of Life Inventory; STAI=State-Trait Anxiety Inventory; PDSS-SR=PanicDisorder Severity Scale; K-10=Kessler-10; SDS=SheehanDisability Scale; PHQ-
9=PatientHealthQuestionnaire; DASS-21=DepressionAnxiety Stress Scale-21; SPSQ=Social Phobia ScreeningQuestionnaire;WHODAS-II=WorldHealthOrganizationDisability Assessment Schedule II; SIAS-6=Social Interaction Anxiety Scale; SPS-
6=Social Phobia Scale— Short Form;GADI=GeneralizedAnxietyDisorderAssessment Inventory;WSAS=Work&Social Adjustment Scale; LSAS= Liebowitz Social Anxiety Scale; FQ=FearQuestionnaire; ACQ=Agoraphobic CognitionsQuestionnaire;
BSQ= Body Sensations Questionnaire; MIA =Mobility Inventory for Agoraphobia; TA = Technician Assisted; CA = Clinician Assisted; CL = Clinician-supported; CL = Coach-supported.
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All studies included were assessed for data which could be included
in ameta-analysis of effects sizes at post-treatment comparing internet-
delivered therapy to waiting-list controls. Any variable (e.g. symptoms
of generalized anxiety and worry and co-morbid depression) which
was reported by two or more studies was analyzed. We included the
analysis of depression symptoms, as typically these are measured in
both single diagnosis focused studies and transdiagnostic. Eleven stud-
ies reported data for both active interventions and control groups (all
were waiting-list controls) which could be used. If different measures
were used these were combined if they measured the same construct.
For example studies reporting scores on the PHQ-9 (Spitzer et al.,
1999) and Beck Depression Inventory-II (Beck et al., 1996) were
combined into a ‘self-reported depression’ category. Three studies
(Andersson et al., 2012; Johnston et al., 2011; Robinson et al., 2010)
had two active intervention conditions as they compared different
types of internet-delivered therapy. Data from both intervention condi-
tions was included in themeta-analysis. We decided to exclude comor-
bid anxiety disorders in the analysis due to the fact that many of the
studies were transdiagnostic, multiple anxiety disorders focused, and
interventions.
All available data was continuous and was therefore analyzed using
standardizedmean difference (Cohens d),weighted by sample size via a
random effects model with 95% conﬁdence interval to compare post-
treatment scores between waiting-list controls and active samples.
There was insufﬁcient data to analyze outcomes at follow-up. The prin-
cipal measures for GAD symptoms were the Generalized Anxiety
Disorder-Q-IV (Newman et al., 2002) and Generalized Anxiety
Disorder-7 (Spitzer et al., 2006), and for pathological worry themeasure
was the Penn State Worry Questionnaire (Meyer et al., 1990).
We also calculated homogeneity of \effect size using the I2-statistic
that indicates heterogeneity as a percentage. A value of 0% indicates
no observed heterogeneity, larger values represent increases in hetero-
geneity, for instance 25% is considered low, 50% as moderate and 75%
considered high heterogeneity (Higgins et al., 2003).
5.2.1. Assessment of the quality of the included studies
To assess the validity of the included studieswe employed the risk of
bias assessment developed by Higgins and Green (2009) for the
Cochrane Collaboration. The ﬁrst two authors (DR, TR) assessed the
studies on four key questions; 1.Was the allocation sequence adequate-
ly generated (Selection Bias)? 2. Was allocation adequately concealed
(Selection Bias)? 3. Was knowledge of the allocated interventions ade-
quately prevented during the study (Performance Bias)? and 4. Were
outcome assessments adequately managed (Detection Bias)?
6. Results
6.1. Selection and inclusion of studies
From the database searches twenty studies (n= 20) were included
into the systematic review. Twelve of these studies were selected for in-
clusion in the meta-analysis. Four studies were GAD speciﬁc samples
and interventions (Andersson et al., 2012; Paxling et al., 2011; Robinson
et al., 2010; Titov et al., 2009), the remainder were transdiagnostic. One
author alerted us to another study that we missed in our search in June
2013 as the paper was published in July 2013 (Johansson et al., 2013);
we also came upon a newly published paper in our second search before
submitting themanuscript for publication (Berger et al., 2013), we decid-
ed to include these studies as they compliedwith our established eligibil-
ity criteria.
One study conducted telephoneMINI interviews to conﬁrm diagnosis
of GAD and/or MDD (Major Depressive Disorder) (Newby et al., 2013).
We decided to include the data from this study as all had primary diagno-
sis of GAD or had a diagnosis of MDD with signiﬁcant subthreshold GADsymptoms. In conclusion, we received discrete outcomes for GAD diag-
nosed subjects from the authors of 7 transdiagnostic studies (Bell et al.,
2012; Berger et al., 2013; Johansson et al., 2013; Johnston et al., 2011;
Newby et al., 2013; Titov et al., 2010; Titov et al., 2011).
We had to exclude the use of data from 1 study (the authors could
not supply the discrete data for GAD diagnosed participants), which
meant that we included data from 11 studies in this meta-analysis.
Fig. 1 shows the results of the systematic search and the reasons for
exclusion.
6.2. Overview of the studies included
Selected characteristics of the studies can be found in Table 1. In total
we were able to include 11 distinct studies that reported on outcomes
from disorder-speciﬁc or transdiagnostic treatments for generalized
anxiety disorder. In the 11 studies 771 participantswere included either
as part of active treatments (n= 371) or as waiting-list controls (n=
400).
Themajority of participants were recruited via awebsite where they
visited or had already registered their interest prior to the trial. It seems
that all of the Australian studies recruited through a website (www.
virtualclinic.org.au) alongside a community-based newspaper advert
in one case (Johnston et al., 2011). Most other studies also relied on
self-recruitment through websites advertising the studies and adverts
in local community newspapers. In one case recruitment was from sev-
eral countries (Berger et al., 2013). Samples were community-based,
apart from Bell et al. (2012) who recruited from a clinical population,
and ranged in size from 48 participants (Titov et al., 2011) to 150 partic-
ipants (Robinson et al., 2010), themean sample size across the 11 stud-
ies was 99 participants.
After completing initial screening and intake questionnaires, all of
the studies administered either the Structured Clinical Interview for
DSM-IV Axis I Disorders (SCID-I; First et al., 1997), theMini Internation-
al Neuropsychiatric Interview Version 5.0.0 (MINI; Sheehan et al.,
1998), or an interview based on theMINI (Johansson et al., 2013) to es-
tablish a formal diagnosis of GAD. The majority administered the inter-
view over phone while one administered the interview in person
(Johansson et al., 2013; Newby et al., 2013). All of the studies employed
what can be considered robust and usual measures to assess outcomes
from treatment. These included for themost part the Generalized Anxiety
Disorder Inventory-7 (GAD-7), and the Penn State Worry Questionnaire
(PSWQ). Berger et al. (2013) argued that because not all participants suf-
fered from the same primary anxiety disorder, disorder-unspeciﬁc mea-
sures were employed to assess primary outcomes, namely the Beck
Anxiety Inventory (BAI; Beck & Robert, 1993). The study did include sec-
ondary outcome measures for speciﬁc anxiety disorders, such as the So-
cial Phobia Scale (SPS). Something similar is witnessed in some studies
that delivered a transdiagnostic treatment, a mix of primary and second-
arymeasureswere used to discretely assess outcomes among the anxiety
disorders (Johnston et al., 2011; Titov et al., 2010; Titov et al., 2011).
Four of the studies can be considered disorder-speciﬁc, whose inter-
ventions directly address generalized anxiety disorder (Andersson et al.,
2012; Paxling et al., 2011; Robinson et al., 2010; Titov et al., 2009). The
remaining seven studies were transdiagnostic in that they were direct-
ed at either multiple anxiety disorders (Berger et al., 2013; Johnston
et al., 2011; Titov et al., 2010) or anxiety disorders and depression
(Johansson et al., 2013; Newby et al., 2013; Titov et al., 2011). The treat-
ment intervention delivered in 9 of the 11 studies was based on cogni-
tive and behavioral principles. Two studies employed a psychodynamic
intervention (Andersson et al., 2012; Johansson et al., 2013). All of the
studies involved an individual treatment format and the treatments
were predominately delivered over 8 sessions of content on a weekly
basis (Andersson et al., 2012; Berger et al., 2013; Johnston et al., 2011;
Paxling et al., 2011; Titov et al., 2011), or with an extended delivery
time of 10 weeks (Johnston et al., 2011, Titov et al., 2011, Johansson
et al., 2013). Four interventions were delivered in 6 modules of content
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et al., 2010; Titov et al., 2009). The GAD treatment in Bell et al. (2012)
consisted of 4 lessons to be completed within 12 weeks.
In line with best practice in internet-delivered treatments for anxi-
ety and depression (Newman et al., 2011; Richards & Richardson,
2012) support for participants was provided in most of the treatment
conditions. Support was provided by therapists in all conditions at var-
ious stages of training in clinical psychology, masters or doctorate
courses. In some cases, qualiﬁed and experienced therapists/clinical
psychologists provided participant support. In the case of Johnston
et al. (2011) the coach supporter was a graduate psychologist with no
further postgraduate training. Bell et al. (2012) did not provide thera-
peutic support for their participants; a research assistant provided
short, highly structured phone calls every 2 weeks.6.3. Overview of the studies excluded
Studies that did not meet our eligibility criteria as outlined in the
methodwere therefore excluded from themeta-analysis. Selected char-
acteristics of the studies can be found in Table 1. In these studies, 2682
participants were included either as part of active treatments (n =
2108) or as waiting-list controls (n=574). Participants were recruited
from the community throughwebsites (Boettcher et al., 2014; Carlbring
et al., 2011; Dear et al., 2011; Klein et al., 2011), or from clinical popula-
tions via referral from GPs or mental health practitioners (Craske et al.,
2011; Draper et al., 2008; Mewton et al., 2012; Sunderland et al., 2012;
Zou et al., 2012). Sample size ranged from 3 (Draper et al., 2008) to
1,004 (Craske et al., 2011). Most studies used one or more self-report
measures to assess anxiety. Most studies included a measure that
speciﬁcally assessed GAD, such as the Generalized Anxiety Disorder
Inventory-7 (GAD-7) (Dear et al., 2011; Mewton et al., 2012;
Sunderland et al., 2012; Zou et al., 2012); and the Penn State Worry
Questionnaire (PSWQ) (Dear et al., 2011; Draper et al., 2008).
Five studies evaluatedGAD-speciﬁc internet-delivered cognitive-be-
havioral therapy (iCBT) interventions (Craske et al., 2011; Draper et al.,
2008; Klein et al., 2011; Mewton et al., 2012; Sunderland et al., 2012).
Two studies looked at transdiagnostic internet-delivered CBT programs:
one for anxiety disorders (Zou et al., 2012), and one for comorbid anxi-
ety anddepression (Dear et al., 2011). Carlbring et al. (2011) evaluated a
tailored internet-delivered CBT approach where clients are assigned 6–
10 out of a possible 16modules for anxiety disorders based on their spe-
ciﬁc diagnosis or diagnoses. The ﬁnal study evaluated a transdiagnostic
internet-basedmindfulness treatment for the anxiety disorders. The in-
tervention programs in the studies ranged from5modules over 8weeks
to 12modules over 12weeks. In linewith best practice, most studies in-
cluded support from a practitioner, by telephone, e-mail or instantmes-
saging. Outcomes from across the studies are positive for the clinical
beneﬁt of internet-delivered interventions for GAD.6.4. Quality assessment
Regarding the methodological quality of the studies, they can be
considered robust. See Fig. 2. Risk of bias graph.Fig. 2. Risk of b6.5. Meta-analysis results: effects of internet-delivered interventions
Results from the meta-analysis are shown in Table 2. Sample sizes
for the individual analyses ranged from 66 to 344 in the treatment
conditions. There were statistically signiﬁcant improvements for
internet-delivered interventions compared to waiting-list controls on
self-reported GAD symptoms (d =−0.91; CI: 1.25–0.56; n = 8) and
pathological worry (d=−0.74; CI: 0.96–0.52; n= 10), both yielding
what can be considered large effects (Cohen, 1988). Similar statistically
signiﬁcant large effects can be noted for the active treatments compared
to waiting-list controls for comorbid anxiety (d=−0.57), depression
(d=−0.63), distress (d=−0.91), disability (d=−0.77), and quality
of life (d= 0.38). Figs. 3 and 4 display forest plots for the primary out-
come variables of GAD andWorry. Figs. 5 and 6 display funnel plots for
these variables. The funnel plot for Worry (Fig. 6) is relatively symmet-
rical suggesting no clear publication bias. However GAD (Fig. 5) is some-
what asymmetrical suggesting some publication bias.
There was high heterogeneity observed for GAD (I2 = 77%) and de-
pression (I2 = 68%), moderate heterogeneity observed for worry (I2 =
46%), and distress (I2 = 39%), for the other variables the observed het-
erogeneity was not signiﬁcant. Given themoderate to high heterogene-
ity observed for some variables it would suggest signiﬁcant variance in
the distribution of the effect sizes reported. However, with the removal
of the psychodynamic studies (Andersson et al., 2012; Johansson et al.,
2013) the results indicate a reduction in heterogeneity and an increase
in effect of the two main constructs, namely generalized anxiety symp-
toms (I2 = 49%; d= 1.19) and worry (I2 = 17%; d= 0.87). There was
statistically signiﬁcant variation for GAD, worry, and depression, how-
ever, changing from a random to ﬁxed-effects model had little impact
on effect sizes, suggesting that heterogeneity for these variables was
not problematic.
Three studies (Johansson et al., 2013; Newby et al., 2013; Titov et al.,
2011) included participants with depression and anxiety disorders,
however, with the exclusion of these subjects with depression and anx-
iety, the effect size for depression remained the same d = −0.63
(−1.03,−0.91).
Sub-group analyses were conducted to compare studies whichwere
GAD speciﬁc to studies which were transdiagnostic (speciﬁcally
transdiagnostic or included comorbid depression or other anxiety disor-
der). For GAD subjects, effect sizes were similar for GAD-speciﬁc
(d = −0.81; CI: −1.27, −0.35, n = 4, p b .001) and transdiagnostic
(d=−.91; CI:−1.25,−0.56, n= 4, p b .001). The difference between
these subgroups was not statistically signiﬁcant: χ2 = 0.34, df = 1,
p N .05. For worry the effect sizes were also similar for GAD-speciﬁc
(d = −0.68; CI: −0.97, −0.38, n = 5, p b .001) and transdiagnostic
(d=−0.77; CI:−1.12,−0.42, n= 4). The difference between these
subgroups was not statistically signiﬁcant: χ2 = 0.16, df= 1, p N .05.
7. Discussion
The paper sought to establish whether the published studies on
internet-delivered treatment for GAD, comparing active treatment in-
terventions with a waiting-list control, were efﬁcacious. The meta-
analysis results demonstrate signiﬁcant post-treatment gains on a num-
ber of measures for internet-delivered interventions for generalizedias graph.
Table 2
Results from the meta-analysiss.
Variable Studies included Number participants treatment (control) Heterogeneity I2, Q Standardized mean difference (upper, lower) Overall effect
GADi n = 8a 321 (249) 77%: χ2 = 42.68, p b 0.00001 −0.91 (−1.25,−0.56) z= 5.10, p b .001
Worryj n = 10b, c, d, o 342 (257) 46%: χ2 = 23.90, p = 0.03 −0.74 (−0.96,−0.52) z= 6.59, p b .001
Anxietyk n = 3i 92 (76) 1%: χ2 = 3.02, p = 0.39 −0.57 (−0.86,−0.27) z = 3.81, p b .001
Depressionl n = 10e 344 (270) 66%: χ2 = 38.36, p = 0.0003 −0.63 (−0.90,−0.35) z= 4.44, p b .001
Distressm n = 4f 173 (133) 39%: χ2 = 6.54, p = 0.16 −0.91 (−1.20,−0.61) z= 6.01, p b .001
Disabilityn n = 5g 209 (152) 0%: χ2 = 4.7, p = 0.58 −0.77 (−0.97,−0.57) z= 7.63, p b .001
Quality of lifeo n = 2h 87 (70) 0%: χ2 = 1.07, p = 0.77 0.38 (0.08, 0.67) z = 2.51, p b .01
a Andersson et al. (2012), Johansson et al. (2013), Johnston et al. (2011), Newby et al. (2013), Paxling et al. (2011), Robinson et al. (2010), Titov et al. (2009), Titov et al. (2011).
b Andersson et al. (2012), Bell et al. (2012), Berger et al. (2013), Johnston et al. (2011), Newby et al. (2013), Paxling et al. (2011), Robinson et al. (2010), Titov et al. (2009), Titov et al.
(2010), Titov et al. (2011).
c Berger et al. (2013), Johnston et al. (2011), Titov et al. (2010), Titov et al. (2011).
d Johnston et al. (2011), Titov et al. (2010), Titov et al. (2011).
e Andersson et al. (2012), Berger et al. (2013), Johannson et al. (2013), Johnston et al (2011), Newby et al. (2013), Paxling et al. (2011) ,Robinson et al. (2010), Titov et al. (2009), Titov
et al. (2011).
f Newby et al. (2013), Robinson et al. (2010), Titov et al. (2009), Titov et al. (2011).
g Johnston et al. (2011), Newby et al. (2013), Robinson et al. (2010), Titov et al. (2009), et al. (2011).
h Anderson et al. (2012), Paxling et al. (2011).
i Andersson et al. (2012), Bell et al. (2012), Paxling et al. (2011).
j GAD-IV, Generalized Anxiety Disorder Question 7 Item Version, Generalized Anxiety Disorder Questionnaire IV.
k Penn State Worry Questionnaire.
l Beck Anxiety Inventory.
m Patient Health Questionnaire 9 Item Version, Beck Depression Inventory II.
n Kessler Distress Scale.
o Sheehan Disability Scale, WHO Disability Assessment Schedule version 2.
o Quality of Life Inventory.
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GAD symptoms a signiﬁcant post-treatment effect was found for partic-
ipants both across the studies included and the various interventions,
compared to thewaiting-list control participants. A similar picture is re-
vealed for pathological worry, a central construct in generalized anxiety
disorder, where participants in the active treatment yielded a large
post-treatment effect compared to the outcomes from the participants
in the waiting-list.
Participants in all cases had a DSM diagnosis of GAD prior to treat-
ment and robust and usual post-treatmentmeasures for GAD and path-
ological worrywere employed to assess outcomes (GAD, GAD-Q-IV and
PSWQ).With this inmind, the data from themeta-analysis supports the
efﬁcacy of internet-delivered treatments for generalized anxiety disor-
der compared to waiting-list controls. The large effect size reported is
similar to the post-treatment outcome from face-to-face studies of
GAD where a waiting-list control groups were also used. For instance,
Cuijpers et al. (2014) report a post-treatment outcome based on 38
comparisons (from 28 studies) of d= 0.84.
The evidence from our analysis supports the efﬁcacy of internet-
based disorder-speciﬁc (4 studies) and transdiagnostic treatment pro-
tocols (7 studies) and those that use CBT-based treatment protocols (9Fig. 3. Forest pstudies). The evidence is limited for psychodynamic therapy, indeed
one of the studies (Andersson et al., 2012) had a rather unexpected im-
provement in the waiting list.
Although the current meta-analysis did not include a comparison
with face-to-face CBT studies, it is encouraging to note that outcomes
for pathological worry in patients with GAD could possibly be similar
to what has been reported in the face-to-face CBT literature. The evi-
dence supports CBT as a highly effective treatment on symptoms of
pathological worry associated with generalized anxiety disorder
(Covin et al., 2008). Hanrahan et al. (2013) analyzed studies that sought
to address this primary symptom of GAD and therefore those that in-
cluded the PSWQ as a primary outcomemeasure. The study of cognitive
therapy versus awaiting-list control reported a large post-treatment ef-
fect size d = 1.81 (Hanrahan et al., 2013). In comparison, the present
meta-analysis shows a smaller effect for pathological worry as mea-
sured by PSWQ(d=−0.74) across the studies and for CBT-based inter-
ventions only (d=0.87); however these effects can be considered large
(Cohen, 1988). It is important to bear inmind that the face-to-face stud-
ies are likely to have higher GAD symptom presence and lower levels of
initial symptom heterogeneity; both of which Cohen's d is sensitive to.
Similarly, the recent paper by Cuijpers et al. (2014), based on 20 studieslot: GAD.
Fig. 4. Forest plot: Worry.
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pathological worry. It seems that face-to-face may have a stronger im-
pact on pathological worry, although this may be confounded by the
fact that many face-to-face interventions actually take more distressed
people so they have more space to improve.7.1. Comorbid depression
It is not unusual to ﬁnd depression as a signiﬁcant comorbidity with
generalized anxiety disorder (Kessler et al., 2005b). The present study
found a signiﬁcant positive shift in depression symptoms from pre- to
post-treatment in comparison to waiting-list controls d=0.63. This ef-
fect is similar to that found for various psychological treatments for de-
pression in general (Cuijpers et al., 2011); for instance, an analysis of
215 comparisons based on 147 studies for the psychological treatment
for depression vs. a control group found an overall effect of d = 0.66,
and similar to the present analysis heterogeneity was moderate to
high. More particularly, based on 94 comparisons from 75 studies of
cognitive-behavioral therapy for depression in adults vs. a control
group yielded an effect size of g= 0.71 (Cuijpers et al., 2013). Interest-
ingly, in both of these meta-analyses when the authors adjusted for
publication bias, effects returned decreased to d=0.53 and g=0.53 re-
spectively. Another recent meta-analysis for psychological treatments
for GAD, that included a small number (n = 5) of internet-delivered
treatments demonstrated an effect size of g = 0.71 for depressionFig. 5. Funnel plot: GAD.post-treatment compared to a control group (Cuijpers et al., 2014). It
would seem that in addition to psychotherapy (face-to-face and inter-
net-delivered) having a positive impact on symptoms of generalized
anxiety disorder it alsohas a signiﬁcant positive impact on comorbid de-
pression that may have existed in relation to primary symptoms. Addi-
tionally, impact on depression was not confounded by studies that had
mixed anxiety and depression participants.7.2. Psychological distress and quality of life
The current study was able to analyze the results of the Kessler-10
(K-10) measure (Kessler et al., 2003) from 4 studies and demonstrated
a signiﬁcant improvement (d =−0.91) in post-treatment distress in
comparison to the waiting-list controls. Anxiety, generalized anxiety
disorder, as with all mental health difﬁculties can cause signiﬁcant dis-
tress to persons and therefore realizing a signiﬁcant reduction in comor-
bid distress is a positive result for internet-delivered treatments.
More particularly, generalized anxiety disorder can cause serious dis-
ability in one's life. The Sheehan Disability Scale (Sheehan, 1983) was
employed by ﬁve of the CBT-based studies in the current meta-analysis
and demonstrates signiﬁcant post-treatment effects (d=−0.77). The re-
sults on a quality of life measure used by 2 studies also conﬁrmed a pos-
itive and signiﬁcant post-treatment effect (d=0.38) in the current study.
These ﬁndings are important given the deleterious effects that GAD can
have on peoples general functioning and well-being (Wittchen, 2002).Fig. 6. Funnel plot: Worry.
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The paper can report a number of potential limitations. First, the
number of studies included is not very high. Although in defense, meth-
odologically the studies are of high quality. Second, with the data, we
could not perform any long-term follow-up to assess maintenance of
gains post-treatment. Third, the main ﬁnding s and secondary analysis
need to be interpreted with caution as the number of study samples
are small, particularly, quality of life, disability, and distress. A further
limitation is the potential publication bias as demonstrated by the forest
plot for GAD. Although we could not complete such a comparison,
Cuijpers et al., 2014 showed that self-rated assessments in GAD has
lower effect sizes compared to clinician administered instruments. In-
cluding studies which had more than one control group in the meta-
analysis is not ideal due to shared variance which may have affected
results slightly. Lastly, it is generally considered sufﬁcient to establish
the efﬁcacy of an intervention against a no-treatment control, but future
research could incorporate comparison against a realistic active control
to measure further the effects of the intervention for GAD symptoms. In
addition, waiting list controls are limited in the period of follow-up
meaning that such analysis of the intervention may be overstated. Cau-
tion is advised regarding the results as the data is limited andhighly het-
erogeneous, but revealing of what future research might be needed.
7.4. Future research
The results are encouraging for the use of internet-delivered treat-
ments for GAD. The pool of publish studies is still small by comparison
to, for example, studies on depression (Richards & Richardson, 2012),
consequently more research in the area would help to build the empir-
ical foundations for the use of internet-delivered interventions for GAD.
There is a greater weight of CBT-based protocols than other therapeutic
orientations and therefore future research could include greater num-
bers of investigations employing varying theoretical approaches. The
limited number and variety of studies alongside small sample sizes
means that there are lots of variables that could not be controlled for
which may have a signiﬁcant impact on outcomes. Future studies
could explore these variables of internet-delivered treatments for GAD
such as the user experience, supporter function, and the possible active
ingredients including the technological tools and features regarding the
presentation of content. Also aswewere unable to conduct any analysis
of maintenance of gains it would be important that studies include
follow-up and report on the results. In addition, the data did not permit
us to conduct subgroups analysis for type of intervention, support type,
dropout and it is recommended that future research might consider
these.
8. Conclusion
The paper aimed to systematically review and analyze all published
studies of internet-delivered treatments for generalized anxiety disor-
der. Signiﬁcant post-treatment gains are established for generalized
anxiety and symptoms of pathological worry. Results are on a par
with face-to-face literature regarding the efﬁcacy of CBT for generalized
anxiety disorder. In addition, we observed signiﬁcant decreases in sev-
eral comorbid behavioral health difﬁculties including depression, dis-
tress and disability. Lastly, while the results are promising and
encouraging for internet-delivered interventions for generalized anxi-
ety disorder further research is needed, especially to establish a more
robust empirical foundation for their effects, to examine other theoret-
ical approaches apart from CBT, to learn more about how we can effec-
tively deliver treatment, to examine follow-up formaintenance of gains,
and explore in more detail subgroups analysis such as differences in ef-
fects for intervention types, support types offered, and retention of
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